Home/ Supplements/ Echinacea/ Echinacea Angustifolia 4:1 Extract Powde...

Echinacea Angustifolia 4:1 Extract Powder

product on market Powder TerraVita Premium Collection Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Echinacea angustifolia root extract is researched for its potential to support immune function and reduce the duration of common cold symptoms. Current clinical evidence for these effects is considered moderate but remains inconsistent across various studies. The ingredient profile is generally recognized as safe for short-term use.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Echinacea Angustifolia 4:1 Extract Powder
Open Full PDF View on NIH DSLD →
Details

Label Data

0.25 Teaspoon(s)
Serving Size
28
Servings
Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 400.0mg (380 products) 36 studies (A:1, B:10)
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions

Additional Information

TerraVita is an exclusive line of premium natural products that use the finest, purest and most potent ingredients in the world. TerraVita's hallmarks are the highest possible standards of purity, potency, stability and freshness. All products are prepared with the greatest quality control, from raw materials through the entire manufacturing process, right up to the moment your product is sealed for freshness and shipped to you.

Please recycle!

Metadata

Product Details

UPC / SKU0 64435 13858 5
DSLD Entry Date2023-04-21
Product TypeBotanical
FormPowder
DSLD ID290518
Data Updated2026-04-11
Research

Research Evidence

38
Research Sources
52
Avg Quality
15
Meta Analysis
12
Systematic Review
6
Rct
2
Clinical Trial
1
Regulatory Source
1
Openfda Safety
A Echinacea for preventing and treating the common cold
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
B Efficacy and safety of Echinacea purpurea in treating upper respiratory infections and complications of otitis media in children: Systematic review and meta-analysis
Meta Analysis Clinical nutrition ESPEN 2025 PubMed DOI
B Echinacea for preventing and treating the common cold
Systematic Review The Cochrane database of systematic reviews 2000 PubMed
B Echinacea Supplementation Does Not Impact Aerobic Capacity and Erythropoiesis in Athletes: A Meta-Analysis
Meta Analysis Nutrients 2024 PubMed DOI
B Echinacea for preventing and treating the common cold
Meta Analysis The Cochrane database of systematic reviews 2006 PubMed
B Therapeutic Potential of a Natural Blend of Aronia melancarpa, Lonicera caerulea, and Echinacea purpurea Extracts in Treating Upper Respiratory Tract Infections: Preliminary Clinical and In Vitro Immunomodulatory Insights
Rct International journal of molecular sciences 2024 PubMed DOI
B Herbal Medicine in Children With Respiratory Tract Infection: Systematic Review and Meta-Analysis
Meta Analysis Academic pediatrics 2018 PubMed DOI
B Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis
Meta Analysis The Lancet. Infectious diseases 2007 PubMed
B Herbal Medicine for Cough: a Systematic Review and Meta-Analysis
Meta Analysis Forschende Komplementarmedizin (2006) 2015 PubMed DOI
B Echinacea for the prevention and treatment of upper respiratory tract infections: A systematic review and meta-analysis
Meta Analysis Complementary therapies in medicine 2019 PubMed DOI
View all evidence for Echinacea →
Compare

Similar Products

View all Echinacea products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.